Loading...
XSHE
000650
Market cap1.08bUSD
Oct 09, Last price  
5.29CNY
1D
1.54%
1Q
0.57%
Jan 2017
-24.96%
Name

Renhe Pharmacy Co.

Chart & performance

D1W1MN
XSHE:000650 chart
P/E
18.71
P/S
2.08
EPS
0.28
Div yield, %
2.88%
Shrs. gr., 5y
1.88%
Rev. gr., 5y
-3.73%
Revenues
3.54b
-13.21%
24,943,408778,664,871876,460,543982,736,8271,366,781,2962,190,667,8462,087,519,1591,799,375,8352,253,212,4342,523,842,6633,567,078,2593,843,771,3514,403,423,4734,581,171,5794,277,798,4884,935,755,2075,153,215,0685,032,146,1234,074,892,9273,536,422,014
Net income
393m
-18.41%
130,301,62139,170,35170,161,003168,720,027219,530,952300,353,372255,461,060194,182,839300,907,596391,303,601372,380,256380,226,704506,464,005537,826,657580,180,496665,024,509574,430,148567,257,503481,911,685393,208,100
CFO
851m
+52.77%
235,279,50335,397,39762,141,462200,579,110130,072,804166,926,090183,966,860213,355,358365,274,345434,765,147522,083,291497,855,600569,454,435693,970,679871,131,642777,717,5301,269,978,522499,469,066557,258,083851,311,999
Dividend
Jul 17, 20260.15182 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Renhe Pharmacy Co., Ltd. is a pharmaceutical enterprise engaged in the manufacturing and distribution of a wide array of products. Its diverse portfolio includes both traditional Chinese and modern Western medicines, their essential raw materials, and various health and wellness items. These offerings are presented in numerous forms, such as oral solid preparations (e.g., tablets, capsules), liquid medications, large and small volume injectable solutions, topical treatments like lotions, liniments, and ointments, as well as suppositories and other health-related product formats. The company, which was established in 1996, maintains its corporate headquarters in Nanchang, China.

Key people

Zhenglian Xiao
Vice Chairman of the Board, Acting General Manager · since 2013
Wei Zhang
General Manager, Director · since 2013
Zhen Wang
Deputy General Manager · since 2017
Ziqiang Zhang
Deputy General Manager · since 2012
Feng Jiang
Secretary of the Board, Director · since 2010
Qiang Mei
Chairman of the Board · since 2013
Qiulin Peng
Chief Financial Officer, Director · since 2010
Jidong Duan
Independent Director · since 2013
Huaping Guo
Independent Director · since 2013
Shutian Tu
Independent Director · since 2013
URL
https://www.renheyaoye.com/photography
IPO date
Dec 10, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT